Envoy Medical (COCH) Stock Statistics & Valuation Metrics

Envoy Medical has a market cap or net worth of $55.37M. The enterprise value is $57.28M.

Market Cap

$55.37M

Enterprise Value

$57.28M

Envoy Medical has 7,744,488 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

7,744,488

Owned by Insiders

40.23%

Owned by Institutions

2.40%

Envoy Medical’s return on equity (ROE) is 2.02 and return on invested capital (ROIC) is 786.93%.

Return on Equity (ROE)

2.02

Return on Assets (ROA)

-2.78

Return on Invested Capital (ROIC)

786.93%

Return on Capital Employed (ROCE)

7.41

Revenue Per Employee

5,604.651

Profits Per Employee

-552.47K

Employee Count

43

Asset Turnover

0.03

Inventory Turnover

0.57

The current PE Ratio of Envoy Medical is -1.90. Envoy Medical’s PEG ratio is -0.01.

PE Ratio

-1.90

PS Ratio

237.88

PB Ratio

-483.90

Price to FCF

-2.45

Price to Operating Cash Flow

-33.32

PEG Ratio

-0.01

In the last 12 months, Envoy Medical had revenue of 241.00K and earned -23.76M in profits. Earnings per share was -12.30.

Revenue

241.00K

Gross Profit

-633.00K

Operating Income

-22.27M

Pretax Income

-23.76M

Net Income

-23.76M

EBITDA

-21.86M

Earnings Per Share (EPS)

-12.30

In the last 12 months, operating cash flow was -22.23M and capital expenditures -205,000, giving a free cash flow of -22.44M billion.

Operating Cash Flow

-22.23M

Free Cash Flow

-22.44M

Free Cash Flow per Share

-0.22

Envoy Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-41.09%

Earnings Yield

-2.83%

Beta

0.13

52-Week Price Change

-1.54%

50-Day Moving Average

6.81

200-Day Moving Average

6.88

Relative Strength Index (RSI)

61.19

Average Volume (3m)

13.81K

Envoy Medical upcoming earnings date is Apr 06, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 05, 2026

Next Earnings Date

Apr 06, 2027

Ex-Dividend Date

―

Envoy Medical as a current ratio of 0.54, with Debt / Equity ratio of -7.81%

Current Ratio

0.54

Quick Ratio

0.41

Debt to Market Cap

0.06

Net Debt to EBITDA

0.13

Interest Coverage Ratio

-14.01

In the past 12 months, Envoy Medical has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

Envoy Medical EV to EBITDA ratio is -2.07, with an EV/FCF ratio of -1.82.

EV to Sales

176.66

EV to EBITDA

-2.07

EV to Free Cash Flow

-1.82

EV to Operating Cash Flow

-1.84

Envoy Medical has $14.57M in cash and marketable securities with $777.00K in debt, giving a net cash position of $13.79M billion.

Cash & Marketable Securities

$14.57M

Total Debt

$777.00K

Net Cash

$13.79M

Net Cash Per Share

$1.78

Tangible Book Value Per Share

-$0.01

Gross margin is -352.81%, with operating margin of -10151.52%, and net profit margin of -9026.41%.

Gross Margin

-352.81%

Operating Margin

-10151.52%

Pretax Margin

-9026.41%

Net Profit Margin

-9026.41%

EBITDA Margin

-8538.10%

EBIT Margin

-8668.83%

The average price target for Envoy Medical is $21.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

$21.50

Price Target Upside

200.70% Upside

Analyst Consensus

Moderate Buy

Analyst Count

2

Revenue Growth Forecast

11.06%

EPS Growth Forecast

64.70%

Smart Score

2

AI Score

50